ONCY · Oncolytics Biotech Inc.
AI read · Neutral
The AI's read
Oncolytics filed an 8-K saying it issued a press release about preclinical results for pelareorep plus a pan-RAS inhibitor in a RAS-driven colorectal cancer model. The filing names the study but gives no experimental data or outcomes, so the announcement alone does not change how we read the company today.